返回
Neogenomics Inc（NEO）價格
NEO 股價走勢圖
NEO 收益
Neogenomics Inc
$12.79
-0.31%
$-0.04
收盤價：Jan 16, 16:00:00 GMT-5
$12.48
-2.36%
$-0.3
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$12.83
開盤價
$12.83
當日範圍
$12.48 - $13
52週區間
$4.72 - $15.32
交易量
3.7M
平均成交量
2.4M
每股盈餘 (TTM)
-0.89
股息收益率
--
市值
$1.6B
什麼是 NEO？
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company is headquartered in Fort Myers, Florida and currently employs 2,200 full-time employees. The company went IPO on 2012-12-10. The firm offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. The company operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.